Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Pharmacology|December 1, 2005
Glucose concentration-dependent potentiation of insulin secretion by a new chemical entity, KCP256Kiyotoshi Mori, Kotaro Takasaki, Yoshimitsu Katoh, et al.
European Journal of Pharmacology|November 1, 2002
KF24345, an adenosine uptake inhibitor, ameliorates the severity and mortality of lethal acute pancreatitis via endogenous adenosine in miceTohru Noji, Ken-ichiro Nan-ya, Mirai Mizutani, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissuesYasuhiro Miki, Taisuke Nakata, Takashi Suzuki, et al.
The Prostate|January 24, 2008
A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditionsKumiko Maruyama-Takahashi, Naoki Shimada, Teruyoshi Imada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A neutralizing anti-fibroblast growth factor 8 monoclonal antibody shows potent antitumor activity against androgen-dependent mouse mammary tumors in vivoNaoki Shimada, Toshihiko Ishii, Teruyoshi Imada, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2014
Synthetic studies on mitotic kinesin Eg5 inhibitors: synthesis and structure-activity relationships of novel 2,4,5-substituted-1,3,4-thiadiazoline derivativesJunichiro Yamamoto, Nobuyoshi Amishiro, Kazuhiko Kato, et al.
International Journal of Cancer|December 15, 2005
Inhibition of bone-derived insulin-like growth factors by a ligand-specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD/SCID mouseKazuhiro Araki, Takafumi Sangai, Shin'ichi Miyamoto, et al.
Cancer Research|July 23, 2003
A novel telomerase template antagonist (GRN163) as a potential anticancer agentAkira Asai, Yuko Oshima, Yoshihiro Yamamoto, et al.
Cancer Research|April 9, 2009
K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cellsRyuichiro Nakai, Shin-ichi Iida, Takeshi Takahashi, et al.
Pageof 2